In the latest session, Hookipa Pharma Inc (NASDAQ: HOOK) closed at $0.64 down -2.42% from its previous closing price of $0.66. In other words, the price has decreased by -$0.0159 from its previous closing price. On the day, 733716 shares were traded. HOOK stock price reached its highest trading level at $0.6558 during the session, while it also had its lowest trading level at $0.6105.
Ratios:
For a deeper understanding of Hookipa Pharma Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.44 and its Current Ratio is at 3.44. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.01.
Morgan Stanley Downgraded its Overweight to Equal-Weight on November 12, 2021, while the target price for the stock was maintained at $6.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 21 when Kandera Reinhard bought 7,000 shares for $0.72 per share. The transaction valued at 5,075 led to the insider holds 43,092 shares of the business.
Kandera Reinhard bought 8,000 shares of HOOK for $5,712 on Aug 16. The Chief Financial Officer now owns 36,092 shares after completing the transaction at $0.71 per share. On Jul 11, another insider, Aldag Jorn, who serves as the Chief Executive Officer of the company, bought 5,000 shares for $0.83 each. As a result, the insider paid 4,142 and bolstered with 71,952 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HOOK now has a Market Capitalization of 63.34M and an Enterprise Value of -40.48M. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.61 while its Price-to-Book (P/B) ratio in mrq is 0.57. Its current Enterprise Value per Revenue stands at -1.97 whereas that against EBITDA is 0.62.
Stock Price History:
Over the past 52 weeks, HOOK has reached a high of $2.05, while it has fallen to a 52-week low of $0.41. The 50-Day Moving Average of the stock is 0.6953, while the 200-Day Moving Average is calculated to be 0.7619.
Shares Statistics:
For the past three months, HOOK has traded an average of 2.51M shares per day and 546.65k over the past ten days. A total of 83.95M shares are outstanding, with a floating share count of 59.47M. Insiders hold about 29.16% of the company’s shares, while institutions hold 41.51% stake in the company. Shares short for HOOK as of Jan 31, 2024 were 446.12k with a Short Ratio of 0.18, compared to 785.43k on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 0.45% and a Short% of Float of 0.46%.
Earnings Estimates
There are 4 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.19 for the current quarter, with a high estimate of -$0.17 and a low estimate of -$0.21, while EPS last year was -$0.17. The consensus estimate for the next quarter is -$0.12, with high estimates of -$0.06 and low estimates of -$0.22.
Analysts are recommending an EPS of between -$0.66 and -$0.85 for the fiscal current year, implying an average EPS of -$0.79. EPS for the following year is -$0.39, with 4 analysts recommending between -$0.01 and -$0.87.
Revenue Estimates
A total of 4 analysts believe the company’s revenue will be $4.55M this quarter.It ranges from a high estimate of $6M to a low estimate of $3.3M. As of the current estimate, Hookipa Pharma Inc’s year-ago sales were $7.83M, an estimated decrease of -41.90% from the year-ago figure. For the next quarter, 2 analysts are estimating revenue of $3.2M, a decrease of -27.10% over than the figure of -$41.90% in the same quarter last year. There is a high estimate of $4M for the next quarter, whereas the lowest estimate is $2.4M.
A total of 5 analysts have provided revenue estimates for HOOK’s current fiscal year. The highest revenue estimate was $25M, while the lowest revenue estimate was $16M, resulting in an average revenue estimate of $18.81M. In the same quarter a year ago, actual revenue was $14.25M, up 32.00% from the average estimate. Based on 4 analysts’ estimates, the company’s revenue will be $16.91M in the next fiscal year. The high estimate is $30M and the low estimate is $9.45M. The average revenue growth estimate for next year is down -10.10% from the average revenue estimate for this year.
